Mary Christian

Mary Christian serves as the Senior Vice President at C4 Therapeutics, Inc. since July 2023, and holds multiple advisory roles including Scientific Advisory Board Member at Promakhos Therapeutics and Strategic Advisor at Syntis Bio. Previously, Mary Christian was Senior Vice President of Regulatory & Quality at Lyndra Therapeutics and Vice President of Global Quality, Regulatory & Safety at Cyclerion. Mary's extensive background includes significant positions at Bristol-Myers Squibb, where leadership was provided in oncology collaborations and global regulatory strategy. Mary Christian's educational qualifications include a BS in Pharmacy from Rutgers University, an MBA in Pharmaceutical Business from the University of the Sciences in Philadelphia, and a Pharm.D. in Clinical Pharmacy from the University of Florida. Additionally, Mary completed the FT Board Director Programme, earning a Non-Executive Director Diploma.